Page last updated: 2024-08-16

trimebutine and loperamide

trimebutine has been researched along with loperamide in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's2 (33.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Cianchetta, G; Cruciani, G; Fravolini, A; Giesing, D; Singleton, RW; Vaz, RJ; Wildgoose, M; Zhang, M1
Mearin, F1
Akuzawa, S; Funatsu, T; Hirata, T; Keto, Y; Miyata, K; Sasamata, M1
El-Din, GM; Elqudaby, HM; Mohamed, GG1
Hirai, T; Iwase, M; Kiuchi, Y; Kurata, N; Namba, H; Nishimura, Y1
Doi, M; Iwasa, T; Masuda, H; Matsumoto, K; Miyoshi, Y; Niikura, N; Sagara, Y; Sakai, H; Shimomura, A; Takahashi, M; Takano, T; Tanabe, Y; Tokunaga, S; Tsurutani, J; Yoshimura, K1

Reviews

1 review(s) available for trimebutine and loperamide

ArticleYear
[Drug treatment of irritable bowel syndrome: an unmet need].
    Gastroenterologia y hepatologia, 2007, Volume: 30, Issue:3

    Topics: Abdominal Pain; Analgesics; Antidepressive Agents, Tricyclic; Antidiarrheals; Carbolines; Controlled Clinical Trials as Topic; Diarrhea; Dicyclomine; Gastrointestinal Agents; Humans; Irritable Bowel Syndrome; Life Style; Loperamide; Meta-Analysis as Topic; Morpholines; Muscarinic Antagonists; Odds Ratio; Parasympatholytics; Phenethylamines; Quality of Life; Risk; Scopolamine; Scopolamine Derivatives; Serotonin Antagonists; Serotonin Receptor Agonists; Surveys and Questionnaires; Time Factors; Treatment Outcome; Trimebutine

2007

Trials

1 trial(s) available for trimebutine and loperamide

ArticleYear
Efficacy of probiotics and trimebutine maleate for abemaciclib-induced diarrhea: A randomized, open-label phase II trial (MERMAID, WJOG11318B).
    Breast (Edinburgh, Scotland), 2023, Volume: 71

    Topics: Breast Neoplasms; Constipation; Diarrhea; Female; Humans; Loperamide; Probiotics; Quality of Life; Trimebutine

2023

Other Studies

4 other study(ies) available for trimebutine and loperamide

ArticleYear
A pharmacophore hypothesis for P-glycoprotein substrate recognition using GRIND-based 3D-QSAR.
    Journal of medicinal chemistry, 2005, Apr-21, Volume: 48, Issue:8

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Caco-2 Cells; Fluoresceins; Fluorescent Dyes; Humans; Models, Molecular; Multivariate Analysis; Permeability; Quantitative Structure-Activity Relationship

2005
Inhibitory effects of ramosetron, a potent and selective 5-HT3-receptor antagonist, on conditioned fear stress-induced abnormal defecation and normal defecation in rats: comparative studies with antidiarrheal and spasmolytic agents.
    Journal of pharmacological sciences, 2008, Volume: 106, Issue:2

    Topics: Animals; Antidiarrheals; Benzimidazoles; Conditioning, Classical; Defecation; Fear; Irritable Bowel Syndrome; Loperamide; Male; Parasympatholytics; Quinolizines; Rats; Rats, Sprague-Dawley; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Stress, Physiological; Trimebutine

2008
Analytical studies on the charge transfer complexes of loperamide hydrochloride and trimebutine drugs. Spectroscopic and thermal characterization of CT complexes.
    Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2014, Aug-14, Volume: 129

    Topics: Gastrointestinal Agents; Indicators and Reagents; Limit of Detection; Loperamide; Spectrophotometry; Spectrum Analysis; Thermogravimetry; Trimebutine

2014
Inhibitory Effects of Gastrointestinal Drugs on CYP Activities in Human Liver Microsomes.
    Biological & pharmaceutical bulletin, 2017, Volume: 40, Issue:10

    Topics: Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Ethanolamines; Gastrointestinal Agents; Humans; Loperamide; Microsomes, Liver; Nonprescription Drugs; Papaverine; Pirenzepine; Trimebutine

2017